Sign Up to like & get
recommendations!
0
Published in 2025 at "Oncology Research"
DOI: 10.32604/or.2025.070031
Abstract: Background Glioblastoma (GBM) remains the most aggressive primary brain tumour in adults, marked by pronounced cellular heterogeneity, diffuse infiltration, and resistance to conventional treatment. In recent years, transcriptomic profiling has provided valuable insights into the…
read more here.
Keywords:
systematic review;
biology;
expression;
gene ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1166104
Abstract: Introduction Glioblastoma is the most common and malignant primary brain tumour with median survival of 14.6 months. Personalised medicine aims to improve survival by targeting individualised patient characteristics. However, a major limitation has been application…
read more here.
Keywords:
glioblastoma systematic;
personalised therapeutic;
systematic review;
therapeutic approaches ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12030402
Abstract: Glioblastoma, as the most aggressive brain tumor, is associated with a poor prognosis and outcome. To optimize prognosis and clinical therapy decisions, there is an urgent need to stratify patients with increased risk for recurrent…
read more here.
Keywords:
glioblastoma systematic;
prognosis;
review;
radiogenomic predictors ... See more keywords